Scinopharm Taiwan Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCINOPHARM TAIWAN
SCINOPHARM TAIWAN has five approved drugs.
Summary for Scinopharm Taiwan
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Patent Litigation for Scinopharm Taiwan: | See patent lawsuits for Scinopharm Taiwan |
Drugs and US Patents for Scinopharm Taiwan
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scinopharm Taiwan | FONDAPARINUX SODIUM | fondaparinux sodium | SOLUTION;SUBCUTANEOUS | 208615-001 | Nov 14, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Scinopharm Taiwan | FONDAPARINUX SODIUM | fondaparinux sodium | SOLUTION;SUBCUTANEOUS | 208615-004 | Nov 14, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Scinopharm Taiwan | FONDAPARINUX SODIUM | fondaparinux sodium | SOLUTION;SUBCUTANEOUS | 208615-003 | Nov 14, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
